To the Editor.—
With the increasing use of gold in the treatment of rheumatoid arthritis, and possibly in pemphigus,1 an increasing incidence of dermatological complications of gold therapy may be expected. This letter describes a previously unreported drug reaction to gold.As described by other authors, the spectrum of dermatological complications of gold therapy ranges from the blue-grey-purple lesions of exposed skin the chrysiasis to the nondiagnostic macular, papular, erythematous rashes that are the most common form of skin eruption in chrysotherapy.2 Classifiable skin eruptions that are due to gold therapy include lichen planus-like and pityriasis rosea-like lesions, urticaria, erythema nodosum, exfoliative dermatitis, seborrheic dermatitis, erythema multiforme, pemphigus-like lesions, alopecia, granuloma annulare, and psoriasiform eruptions.2-4A careful search of the literature has failed to reveal any previous report of a patient in whom the skin complication of chrysotherapy manifested itself as actual "glittering" of the skin. The
Kohn SR, Denson LJ. Glittering With Gold Therapy. Arch Dermatol. 1978;114(2):287–288. doi:10.1001/archderm.1978.01640140095031
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: